AQXP Market Cap History
Below is a table of the AQXP market cap history going back to 4/30/2014:

Date AQXP Market Cap
4/30/201497.47M
8/7/201480.21M
11/3/201471.97M
3/12/2015128.93M
5/4/201572.06M
8/5/201518.88M
11/9/2015235.12M
3/10/2016139.07M
5/9/2016133.05M
8/4/2016165.41M
11/9/2016295.60M
3/9/2017408.27M
5/9/2017348.77M
8/8/2017334.61M
11/8/2017259.76M
3/9/2018388.77M
5/8/2018308.19M
8/8/201871.55M
11/7/201859.55M
3/7/201962.84M
4/15/201960.02M
5/7/201963.08M
8/1/201967.32M

Also see: AQXP Shares Outstanding History
and AQXP YTD Return
AQXP Historical Market Cap:
-6.80% CAGR
AQXP Historical Market Cap: +-6.80% CAGR

Mouse over chart for data details
4/30/2014 ...8/1/2019
Aquinox Pharmaceuticals is a clinical-stage pharmaceutical company discovering and developing therapeutics for chronic urological conditions marked by inflammation and pain. Co.'s primary drug candidate, rosiptor, for the treatment of patients with interstitial cystitis/bladder pain syndrome (IC/BPS). Co. is focused on utilizing its library of novel compounds that activate SHIP1 (SH2-containing inositol-5'-phosphatase to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. We show 23 historical shares outstanding datapoints in our AQXP shares outstanding history coverage, used to compute AQXP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AQXP market cap history over the course of time is important for investors interested in comparing AQXP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AQXP versus a peer is one thing; comparing AQXP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AQXP can fluctuate over the course of history. With this page we aim to empower investors researching AQXP by allowing them to research the AQXP market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AQXP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aquinox Pharmaceuticals (AQXP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ARA Market Cap History
ARAV Market Cap History
ARAY Market Cap History
ARCT Market Cap History
ARDM Market Cap History
ARDS Market Cap History
ARDX Market Cap History
ARMO Market Cap History
ARNA Market Cap History
ARPO Market Cap History
More Healthcare companies »

 

AQXP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.